Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention (2019) Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Impact of radon and combinatory radon/carbon dioxide spa on pain and hypertension: Results from the explorative RAD-ON01 study (2019) Rühle PF, Klein G, Rung T, Phan HT, Fournier C, Fietkau R, Gaipl U, Frey B Journal article Temporarily increased TGFβ following radon spa correlates with reduced pain while serum IL-18 is a general predictive marker for pain sensitivity (2019) Kullmann M, Rühle PF, Harrer A, Donaubauer AJ, Becker I, Sieber R, Klein G, et al. Journal article Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands (2019) Haller F, Bieg M, Will R, Koerner C, Weichenhan D, Bott A, Ishaque N, et al. Journal article Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study (2018) Hecht M, Hahn D, Wolber P, Hautmann M, Reichert D, Weniger J, Belka C, et al. Conference contribution Low-Dose Radiotherapy Ameliorates Advanced Arthritis in hTNF-α tg Mice by Particularly Positively Impacting on Bone Metabolism (2018) Deloch L, Derer A, Hueber A, Herrmann M, Schett G, Wölfelschneider J, Hahn J, et al. Journal article, Original article THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE) (2018) Baehr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M Conference contribution Abstracts DEGRO 2018 Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution